WuXi Biologics (Cayman), Inc. (WXIBF)
6.77
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
WuXi Biologics Price : 6.77 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 109.00 |
| Oct 02, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 246.00 |
| Oct 01, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 0.000 |
| Sep 30, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 346.00 |
| Sep 29, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 340.00 |
| Sep 28, 2026 | 6.77 | 6.77 | 6.77 | 6.77 | 332.00 |
| Sep 25, 2026 | 6.74 | 6.77 | 6.74 | 6.77 | 10805.00 |
| Sep 24, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 263.00 |
| Sep 23, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 92.00 |
| Sep 22, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 93.00 |
| Sep 21, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 21.00 |
| Sep 18, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 670.00 |
| Sep 17, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 433.00 |
| Sep 16, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 1113.00 |
| Sep 15, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 24.00 |
| Sep 14, 2026 | 6.01 | 6.01 | 6.01 | 6.01 | 242.00 |
| Sep 11, 2026 | 5.996 | 6.01 | 5.996 | 6.01 | 74601.00 |
| Sep 10, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 511.00 |
| Sep 09, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 14.00 |
| Sep 08, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 1823.00 |
| Sep 04, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 2195.00 |
| Sep 03, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 447.00 |
| Sep 02, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 2327.00 |
| Sep 01, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 248.00 |
| Aug 31, 2026 | 6.225 | 6.225 | 6.225 | 6.225 | 830.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Repligen Corp. | 174.97 |
| Sinovac Biotech Ltd. | 6.47 |
| Bio-Techne Corp. | 72.44 |
| CASI Pharmaceuticals, Inc. | 0.1052 |
| BioLife Solutions, Inc. | 38.61 |
Price Related Metrics
| PE Ratio | 39.71 |
| PS Ratio | 8.363 |
| PEG Ratio | 0.3793 |
| Price to Free Cash Flow | 44.92 |
| Earnings Yield | 2.52% |
| Market Cap | 27.80B |
| PEGY Ratio | 0.3793 |
| Operating PE Ratio | 25.84 |
| Normalized PE Ratio | 42.29 |